SciSparc shares are trading higher. The company announced its majority-owned subsidiary, NeuroThera Labs, has completed two tranches of non-brokered private placements, raising aggregate gross proceeds of C$5.4 million.benzinga_article·Aug 18 at 12:07 PMSPRC+1.06%
SciSparc subsidiary NeuroThera Labs raises C$5.4 million in private placementsPUBT·Aug 18 at 07:06 AMSPRC+1.06%
The Great Pivot: How a Mismatched Cohort of SPACs, Biotechs, and Legacy Giants Are Navigating the New Economic RealityGlobal Report·Aug 18 at 05:12 AMNUVB+1.46%DGXX+3.83%
Neurothera Labs Inc. Closes Final Tranche of Non-Brokered Private PlacementTheNewswire·Aug 17 at 08:10 PMSPRC+1.06%
NeuroThera Labs raises C$ 2.7 million in first tranche of non-brokered private placement at C$ 0.12 per unitPUBT·Aug 12 at 04:01 PMSPRC+1.06%
SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic CombinationUnusual Whales·Aug 12 at 07:27 AMSPRC+1.06%
SciSparc subsidiary NeuroThera Labs’ quantum platform completes end-to-end hybrid workflow for clinical data analyticsPUBT·Jul 31 at 07:20 AMSPRC+1.06%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 29 at 12:06 PMAVTR+1.47%MBRX+0.41%
